Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial

Table 9

Comparison of symptoms during the medical observation period.

Variables	N = 1976		value
	LH group (N = 1101)	Control group (N = 875)
Fever	2 (0.18)	15 (1.71)	<0.001
Pharyngodynia	0 (0.00)	1 (0.11)	0.443
Cough	1 (0.09)	0 (0.00)	1.000
Expectoration	0 (0.00)	1 (0.11)	0.443
Diarrhea	2 (0.18)	0 (0.00)	0.506
Nasal obstruction	1 (0.09)	0 (0.00)	1.000
Rhinorrhea	1 (0.09)	0 (0.00)	1.000